The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review

Matthew T.J. Halma 1,*, Jessica Rose 2 and Theresa Lawrie 1 Independent Researcher Academic Editor: James David Adams Received: 1 January 2023 / Revised: 4 April 2023 / Accepted: 4 April 2023 / Published: 17 April 2023 Abstract Pharmacovigilance databases are showing evidence of injury in the context of the modified COVID-19 mRNA products. According … The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review weiterlesen